Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia.
about
Gestational diabetes and pregnancy outcomes--a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteriaGestational diabetes: A clinical updateObesity epidemic: impact from preconception to postpartum.Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysisDiet restriction in Ramadan and the effect of fasting on glucose levels in pregnancy.Preeclampsia and the risk of large-for-gestational-age infants.Gestational diabetes: risks, management, and treatment options.Consequences of gestational diabetes in an urban hospital in Viet Nam: a prospective cohort studyRisk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway.Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial.Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease.The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes.Low glycaemic index diet in pregnancy to prevent macrosomia (ROLO study): randomised control trial.Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis.Diabetic angiopathy and angiogenic defects.Adiposity and hyperglycaemia in pregnancy and related health outcomes in European ethnic minorities of Asian and African origin: a reviewGestational diabetes mellitus: screening and outcomes in southern italian pregnant women.Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetesThe effect of maternal body mass index on perinatal outcomes in women with diabetes.Clinical presentation and management of diabetes mellitus in pregnancyHypertension complicating diabetic pregnancies: pathophysiology, management, and controversies.Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk.Hyperglycemia down-regulates cGMP-dependent protein kinase I expression in first trimester cytotrophoblast cells.Associations Between Fetal Imprinted Genes and Maternal Blood Pressure in Pregnancy.Clinical significance of fasting plasma glucose in patients with normal 50-g glucose challenge test in pregnancy: Is 100 bigger than 92?Maternal educational level and the risk of persistent post-partum glucose metabolism disorders in women with gestational diabetes mellitus.Effects of Vitamin D Deficiency on Incidence Risk of Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis.Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus.Plasma microRNA-16-5p, -17-5p and -20a-5p: Novel diagnostic biomarkers for gestational diabetes mellitus.Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.Comparisons of the oxidative stress biomarkers levels in gestational diabetes mellitus (GDM) and non-GDM among Thai population: cohort study.
P2860
Q21261351-2D313BF1-28DE-43C8-A32E-5035FAA0F0AAQ26799245-35A1B58D-0EBB-475A-8B09-0D097CD5D8ACQ30239892-1A6BADB4-B0D9-4999-954D-D6F53D61E905Q30245386-09BF0A0B-0FFB-4B6F-B5DF-BA4FEA9C5029Q33869779-B7A49539-BCDB-4C0B-A376-14060394546FQ33924175-E0EC5373-5B8E-46B8-A671-C0F3FC1371DCQ34345691-866BDC6B-F561-4E18-A38A-5DAAB0B9ED5CQ34387198-1623D380-E59E-4ACB-9656-5BD12184C5AAQ34594828-02B455A5-10EB-4622-B98A-0ADC2CE7DE19Q35123459-1D10ADB0-457B-43EC-A3A6-6C54335EC3DCQ35143007-0CB9E338-96EF-4693-8CB3-C0E5A7BE4C13Q35841240-017AB63D-843D-417C-A0BE-88E917BCC872Q36200731-65BED104-1CDB-41F6-B38C-D78147001263Q36208663-135FC8C0-57D4-47DA-B3CA-C723E0B136D6Q36301365-D041B8B4-5B62-4F3A-B8A1-0D388DFCF4E7Q36649021-5140EA74-9A96-4A1E-8BE2-B80953D0F28CQ37182817-99E24BA5-92FC-4B5C-B303-A1B31E1D49B1Q37242929-419E3496-53AF-4C5E-9C5D-8A902A406C83Q37366090-589A35F9-B3C2-4A82-9567-E70A2DFEC4CDQ37396809-CFF033FB-ADCD-4EEA-8B42-C88DBA94FA7EQ37861890-3B4529D0-31DD-4CFF-88D5-FD82D83F7A40Q37990465-C2D0EE05-FD18-42F3-8105-50113F896354Q38888539-DFAA9684-97D9-4F0E-90C7-8B854B4D7598Q39252976-82A6CDA5-16DB-4F87-86AA-3E3B9DF52D5FQ39449916-3E066B43-BD9B-4038-A1EE-E2ACB473611DQ47183111-1ADD4D48-1B4E-4258-94B8-E69AADF12CC1Q49306317-5D50BF8F-0253-4E73-9E80-513633161547Q51285040-7C08887B-2AA2-49A4-B091-FD8483AFFECCQ53736306-F76ED721-0FBA-43C8-9366-4844C5F15C00Q54491741-206F58D4-24AB-4AB9-A436-BC8F9FE5243DQ55018252-3F2A373F-E757-4713-98DD-2B0DB048F09E
P2860
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia.
@ast
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia.
@en
type
label
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia.
@ast
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia.
@en
prefLabel
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia.
@ast
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia.
@en
P2093
P2860
P1476
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia.
@en
P2093
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group
P2860
P304
P356
10.1016/J.AJOG.2010.01.024
P407
P577
2010-03-01T00:00:00Z